Viral Vector Market Size, Share & Trends Report

Viral Vector Market Size, Share & Trends Analysis Report By Vector Type (Adeno-associated Virus (AAV), Adenovirus, Lentivirus, Retrovirus, Others), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-072-3
Number of Pages: 120
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Viral Vector Type Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Adeno-associated virus (AAV)
- Adenovirus
- Lentivirus
- Retrovirus
- Others
Viral Vector Application Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Cell & Gene Therapy
- Vaccine
- Biopharmaceutical & Pharmaceutical Discovery
Viral Vector End-user Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- CROs & CMOs
Vector Viral Market Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
    - Adeno-associated virus (AAV)
    - Adenovirus
    - Lentivirus
    - Retrovirus
    - Others
  - North America Vector viral Market, By Application, 2018 - 2030 (USD Million)
    - Cell & Gene Therapy
    - Vaccine
    - Biopharmaceutical & Pharmaceutical Discovery
  - North America Vector viral Market, By End-user, 2018 - 2030 (USD Million)
    - Academic & Research Institutes
    - CROs & CMOs
    - Pharmaceutical & Biotechnology Companies
  - U.S.
    - U.S. Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - U.S. Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - U.S. Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Canada
    - Canada Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Canada Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Canada Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
- Europe
  - Europe Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
    - Adeno-associated virus (AAV)
    - Adenovirus
    - Lentivirus
    - Retrovirus
    - Others
  - Europe Vector viral Market, By Application, 2018 - 2030 (USD Million)
    - Cell & Gene Therapy
    - Vaccine
    - Biopharmaceutical & Pharmaceutical Discovery
  - Europe Vector viral Market, By End-user, 2018 - 2030 (USD Million)
    - Academic & Research Institutes
    - CROs & CMOs
    - Pharmaceutical & Biotechnology Companies
  - UK
    - UK Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - UK Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - UK Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Germany
    - Germany Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Germany Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Germany Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - France
    - France Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - France Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - France Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Italy
    - Italy Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Italy Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Italy Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Spain
    - Spain Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Spain Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Spain Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Denmark
    - Denmark Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Denmark Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Denmark Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Sweden
    - Sweden Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Sweden Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Sweden Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Norway
    - Norway Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Norway Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Norway Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
- Asia Pacific
  - Asia Pacific Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
    - Adeno-associated virus (AAV)
    - Adenovirus
    - Lentivirus
    - Retrovirus
    - Others
  - Asia Pacific Vector viral Market, By Application, 2018 - 2030 (USD Million)
    - Cell & Gene Therapy
    - Vaccine
    - Biopharmaceutical & Pharmaceutical Discovery
  - Asia Pacific Vector viral Market, By End-user, 2018 - 2030 (USD Million)
    - Academic & Research Institutes
    - CROs & CMOs
    - Pharmaceutical & Biotechnology Companies
  - Japan
    - Japan Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Japan Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Japan Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - China
    - China Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - China Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - China Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - India
    - India Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - India Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - India Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - South Korea
    - South Korea Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - South Korea Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - South Korea Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Australia
    - Australia Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Australia Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Australia Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Thailand
    - Thailand Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Thailand Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Thailand Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
- Latin America
  - Latin America Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
    - Adeno-associated virus (AAV)
    - Adenovirus
    - Lentivirus
    - Retrovirus
    - Others
  - Latin America Vector viral Market, By Application, 2018 - 2030 (USD Million)
    - Cell & Gene Therapy
    - Vaccine
    - Biopharmaceutical & Pharmaceutical Discovery
  - Latin America Vector viral Market, By End-user, 2018 - 2030 (USD Million)
    - Academic & Research Institutes
    - CROs & CMOs
    - Pharmaceutical & Biotechnology Companies
  - Brazil
    - Brazil Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Brazil Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Brazil Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Mexico
    - Mexico Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Mexico Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Mexico Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Argentina
    - Argentina Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Argentina Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Argentina Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
- MEA
  - MEA Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
    - Adeno-associated virus (AAV)
    - Adenovirus
    - Lentivirus
    - Retrovirus
    - Others
  - MEA Vector viral Market, By Application, 2018 - 2030 (USD Million)
    - Cell & Gene Therapy
    - Vaccine
    - Biopharmaceutical & Pharmaceutical Discovery
  - MEA Vector viral Market, By End-user, 2018 - 2030 (USD Million)
    - Academic & Research Institutes
    - CROs & CMOs
    - Pharmaceutical & Biotechnology Companies
  - South Africa
    - South Africa Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - South Africa Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - South Africa Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Saudi Arabia
    - Saudi Arabia Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Saudi Arabia Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Saudi Arabia Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - UAE
    - UAE Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - UAE Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - UAE Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies
  - Kuwait
    - Kuwait Vector viral Market, By Vector Type, 2018 - 2030 (USD Million)
      - Adeno-associated virus (AAV)
      - Adenovirus
      - Lentivirus
      - Retrovirus
      - Others
    - Kuwait Vector viral Market, By Application, 2018 - 2030 (USD Million)
      - Cell & Gene Therapy
      - Vaccine
      - Biopharmaceutical & Pharmaceutical Discovery
    - Kuwait Vector viral Market, By End-user, 2018 - 2030 (USD Million)
      - Academic & Research Institutes
      - CROs & CMOs
      - Pharmaceutical & Biotechnology Companies

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.